Zhejiang Kangyu Pharmaceutical Co., Ltd (Kangyu Pharma) is the core corporation of Apeloa in the field of research, development and production of bulk pharmaceuticals, preparations, pharmaceutical intermediates,and veterinary drugs. Kangyu is a GMP certified factory and as a major national high-tech firm as well as the major pharmaceutical firm in Zhejiang Province.Company has passed the ISO9001 and ISO14001 certification test. It has a campus over 260,000 m2 with over 50,000 m2 in floorage,100,000 m2 afforested area. There are 1350 employees, among them over 30% are technical specialists. Relying on people and technologies, Kangyu is committed to the research, development and production of high-tech products, and to the constant innovation of products being marketed. With the establishment of provincial R&D center and long term fruitful collaborations with first rate research institutions in the country, Kangyu has successfully developed the high-tech award winning Ubenimex capsules, an anti-tumor drug rated as national class 2 new drug as well as major national new drug, and a recipient of level 2 Award of the Progress in Medicinal Science & Technology. The project to develop the drug was listed in the major technological task, and in the national "Torch" plan.

The company has multiple production lines for semi-synthesis, chemical synthesis and pharmaceutical preparations. The products are in five classes: anti-tumor drugs, antiviral drugs, antibiotics, cardiovascular drugs and special drugs. They mainly are :Ubenimex capsules, Rimantadine hydrochloride tablets/oral solution, Cefetamet pivoxil hydrochloride tablets, Azithomycin Citrate Dithydro Sodium Freeze-dry powder injection, Isosorbide Mononitrate Freeze-dry powder injection, Netilmicin Sulfate Freeze-dry powder injection, Compound Mephedrine hydrochloride Oral solution, Indamide tablets, Clarithromycin capsules, Levofloxacin hydrochloride capsules, Ofloxacin(360T/Y,the largest producer in the world),Amantadine hydrochloride series etc.